Yes, the thought had crossed my mind a few times that they were keen to hold the Angelman's result until the Daybue earnings were out of the way - better course of action than the reverse. Keeping the powder dry, so to speak.
If correct, it would suggest that Angelman's is another good to great result.
Can only hope so.
[Appears cruel that such a ground breaking drug as Daybue now appears to be a stone around the neck of Neuren's SP. But hang on, that it not what it's about is it? The important thing is Daybue is kicking goals where it matters most - and that is for the people who are experiencing its undoubted life changing benefits. .... GO DAYBUE.]
Acadia, page-772
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.61 |
Change
0.280(2.10%) |
Mkt cap ! $1.739B | |||
| Open | High | Low | Value | Volume |
| $13.49 | $13.64 | $13.30 | $4.821M | 356.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3602 | $13.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1655 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |